Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 71, 113-123
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohortJournal of Hepatology, 2012
- Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndromeMicrobial Cell Factories, 2011
- Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial CommunitiesApplied and Environmental Microbiology, 2009
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-AnalysisGastroenterology, 2008
- Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markersHepatology, 2008
- Grip strength and the metabolic syndrome: findings from the Hertfordshire Cohort StudyQJM: An International Journal of Medicine, 2007
- The NAFLD fibrosis scoreHepatology, 2007
- Human gut microbes associated with obesityNature, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005